Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 1;45(3):624-633.
doi: 10.2337/dc21-0422.

Heterogeneity of DKA Incidence and Age-Specific Clinical Characteristics in Children Diagnosed With Type 1 Diabetes in the TEDDY Study

Collaborators, Affiliations

Heterogeneity of DKA Incidence and Age-Specific Clinical Characteristics in Children Diagnosed With Type 1 Diabetes in the TEDDY Study

Laura M Jacobsen et al. Diabetes Care. .

Abstract

Objective: The Environmental Determinants of Diabetes in the Young (TEDDY) study is uniquely capable of investigating age-specific differences associated with type 1 diabetes. Because age is a primary driver of heterogeneity in type 1 diabetes, we sought to characterize by age metabolic derangements prior to diagnosis and clinical features associated with diabetic ketoacidosis (DKA).

Research design and methods: The 379 TEDDY children who developed type 1 diabetes were grouped by age at onset (0-4, 5-9, and 10-14 years; n = 142, 151, and 86, respectively) with comparisons of autoantibody profiles, HLAs, family history of diabetes, presence of DKA, symptomatology at onset, and adherence to TEDDY protocol. Time-varying analysis compared those with oral glucose tolerance test data with TEDDY children who did not progress to diabetes.

Results: Increasing fasting glucose (hazard ratio [HR] 1.09 [95% CI 1.04-1.14]; P = 0.0003), stimulated glucose (HR 1.50 [1.42-1.59]; P < 0.0001), fasting insulin (HR 0.89 [0.83-0.95]; P = 0.0009), and glucose-to-insulin ratio (HR 1.29 [1.16-1.43]; P < 0.0001) were associated with risk of progression to type 1 diabetes. Younger children had fewer autoantibodies with more symptoms at diagnosis. Twenty-three children (6.1%) had DKA at onset, only 1 (0.97%) of 103 with and 22 (8.0%) of 276 children without a first-degree relative (FDR) with type 1 diabetes (P = 0.008). Children with DKA were more likely to be nonadherent to study protocol (P = 0.047), with longer duration between their last TEDDY evaluation and diagnosis (median 10.2 vs. 2.0 months without DKA; P < 0.001).

Conclusions: DKA at onset in TEDDY is uncommon, especially for FDRs. For those without familial risk, metabolic monitoring continues to provide a primary benefit of reduced DKA but requires regular follow-up. Clinical and laboratory features vary by age at onset, adding to the heterogeneity of type 1 diabetes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Incidence of type 1 diabetes in TEDDY children (n = 379, solid box) and DKA incidence (open box) by age group. Number of children and study population denominator displayed below each group.
Figure 2
Figure 2
Age-specific HRs (with 95% CIs) associated with a one-unit increase in either fasting glucose (solid box) or 120-min stimulated blood glucose (open box) with regard to progression of type 1 diabetes. The risk of progression to type 1 diabetes was constant over time (age) for baseline levels of fasting and stimulated glucose.

References

    1. International Diabetes Federation . IDF Diabetes Atlas, eighth edition, 2017. Accessed 29 November 2020. Available from https://diabetesatlas.org/upload/resources/previous/files/8/IDF_DA_8e-EN...
    1. Zheng S, Mathews CE. Metabolic abnormalities in the pathogenesis of type 1 diabetes. Vol. 14. Curr Diab Rep 2014;14:519. - PMC - PubMed
    1. Dabelea D, Rewers A, Stafford JM, et al. .; SEARCH for Diabetes in Youth Study Group . Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics 2014;133:e938–e945 - PMC - PubMed
    1. Evans-Molina C, Sims EK, DiMeglio LA, et al. .; Type 1 Diabetes TrialNet Study Group . β Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis. JCI Insight 2018;3:e120877 - PMC - PubMed
    1. Sosenko JM, Palmer JP, Rafkin LE, et al. .; Diabetes Prevention Trial-Type 1 Study Group . Trends of earlier and later responses of C-peptide to oral glucose challenges with progression to type 1 diabetes in diabetes prevention trial-type 1 participants. Diabetes Care 2010;33:620–625 - PMC - PubMed

Publication types